Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 2/20 | 0.51 |
| ▸ | CA9 | Q16790 | 2/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.51 |
| ▸ | MAPT | P10636 | 3/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.51 |
| ▸ | GAPDH | P04406 | 2/20 | 0.49 |
| ▸ | NPC1 | O15118 | 3/20 | 0.49 |
| ▸ | POLB | P06746 | 2/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.49 |
| ▸ | GLA | P06280 | 3/20 | 0.49 |
| ▸ | GAA | P10253 | 2/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 3/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 3/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.48 |
| ▸ | USP2 | O75604 | 2/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
| ▸ | FLT3 | P36888 | 1/20 | 0.47 |
| ▸ | BACE1 | P56817 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10416103 | 0.91 | GAPDH (0.49) | CA12CA9ALDH1A1MAPTSMN1; SMN2 | |
| SCHEMBL12337780 | 0.85 | ALOX15 (0.43) | CA12CA9ALDH1A1MAPTSMN1; SMN2 | |
| SCHEMBL19996956 | 0.85 | ELANE (0.49) | CA12CA9ALDH1A1MAPTSMN1; SMN2 | |
| SCHEMBL17717380 | 0.83 | ELANE (0.49) | CA12CA9ALDH1A1MAPTSMN1; SMN2 | |
| SCHEMBL3320871 | 0.82 | ALOX15 (0.40) | CA12CA9ALDH1A1MAPTSMN1; SMN2 | |
| SCHEMBL28836885 | 0.81 | CA2 (0.40) | CA12CA9ALDH1A1MAPTSMN1; SMN2 | |
| SCHEMBL8968025 | 0.81 | KMT2A (0.48) | CA12CA9ALDH1A1MAPTPOLB | |
| SCHEMBL4204276 | 0.81 | KMT2A (0.51) | CA12CA9ALDH1A1MAPTPOLB | |
| SCHEMBL29426396 | 0.81 | KMT2A (0.51) | CA12CA9ALDH1A1MAPTPOLB | |
| SCHEMBL11908094 | 0.80 | PIK3C3 (0.41) | CA12CA9ALDH1A1MAPTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107653034-A | High-efficiency energy-saving nano carbon molecules based lubricating oil and preparation method thereof | 魏衡 | 2018-02-02 | — | — | CN | claimed |
| CN-120202243-A | Thermosetting resin composition, cured film, substrate, and electronic component | 捷恩智株式会社 | 2025-06-24 | — | — | CN | disclosed |
| CN-115819384-B | Method for preparing phthalic anhydride and derivatives thereof by catalyzing and oxidizing aromatic ketone by V-N-C material | 大连理工大学 | 2024-04-26 | — | — | CN | disclosed |
| CN-109810041-B | Halogenated allylamine SSAO/VAP-1 inhibitor and application thereof | 药捷安康(南京)科技股份有限公司 | 2023-08-15 | — | — | CN | disclosed |
| US-11649233-B2 | Halo-allylamine SSAO/VAP-1 inhibitor and use thereof | NANJING TRANSTHERA BIOSCIENCES CO., LTD. (CN) | 2023-05-16 | — | — | US | disclosed |
| US-11649233-B2 | Halo-allylamine SSAO/VAP-1 inhibitor and use thereof | NANJING TRANSTHERA BIOSCIENCES CO., LTD. (CN) | 2023-05-16 | — | — | US | disclosed |
| US-11649233-B2 | Halo-allylamine SSAO/VAP-1 inhibitor and use thereof | NANJING TRANSTHERA BIOSCIENCES CO., LTD. (CN) | 2023-05-16 | — | — | US | disclosed |
| CN-115819384-A | Method for preparing phthalic anhydride and derivatives thereof by catalytic oxidation of aromatic ketone with V-N-C material | 大连理工大学 | 2023-03-21 | — | — | CN | disclosed |
| US-20220387362-A1 | COMPOSITIONS COMPRISING A DHODH INHIBITOR FOR THE TREATMENT OF ACUTE MYELOID LEUKEMIA | RHIZEN PHARMACEUTICALS AG (CH) | 2022-12-08 | — | — | US | disclosed |
| EP-4048251-A1 | COMPOSITIONS COMPRISING A DHODH INHIBITOR FOR THE TREATMENT OF ACUTE MYELOID LEUKEMIA | Rhizen Pharmaceuticals AG (CH) | 2022-08-31 | — | — | EP | disclosed |
| WO-1995030647-A1 | CCK AND GASTRIN RECEPTOR LIGANDS | JAMES BLACK FOUNDATION LIMITED (GB) | 1995-11-16 | — | — | WO | disclosed |
| US-5446124-A | A copolymer of polylactones and polythioesters; a modifying agent for thermoplastic or thermosetting resins enhancing performance | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1995-08-29 | — | — | US | disclosed |
| EP-0511385-B1 | THERMOPLASTIC GRAFT COPOLYMER AND PRODUCTION THEREOF | SUMITOMO CHEMICAL CO (JP) | 1995-06-14 | — | — | EP | disclosed |
| US-5376730-A | Grafting an aromatic carboxy oligomer to an addition polymer; heat resistant hoses, seals | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1994-12-27 | — | — | US | disclosed |
| EP-0594845-A1 | AROMATIC OLIGOMER AND PRODUCTION THEREOF | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1994-05-04 | — | — | EP | disclosed |
| EP-0567313-A1 | Thermoplastic graft copolymer composition | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1993-10-27 | — | — | EP | disclosed |
| EP-0511385-A1 | THERMOPLASTIC GRAFT COPOLYMER AND PRODUCTION THEREOF | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1992-11-04 | — | — | EP | disclosed |
| US-5153335-A | Reacting halophthalic anhydride and alkali metal salt with acid or acid derivative catalyst | OCCIDENTAL CHEMICAL CORPORATION (US) | 1992-10-06 | — | — | US | disclosed |
| EP-0460687-A2 | Process for the preparation of oxydiphthalic anhydride and acyloxyphthalic anhydrides | OCCIDENTAL CHEMICAL CORPORATION (US) | 1991-12-11 | — | — | EP | disclosed |
| US-4952721-A | AIR OXIDATION WITH HEAVY METAL CATALYSTS | AMOCO CORPORATION (US) | 1990-08-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11649233-B2 | Halo-allylamine SSAO/VAP-1 inhibitor and use thereof | VAPB, VAPA, ADRA1D | CA12 4714/4885CA9 4213/4885ALDH1A1 326/4885 |
| US-20220387362-A1 | COMPOSITIONS COMPRISING A DHODH INHIBITOR FOR THE TREATMENT OF ACUTE MYELOID LEUKEMIA | DHODH, FLT3, IDH3A | CA12 3984/4885CA9 2456/4885ALDH1A1 176/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.